Lupin's Maharashtra Office Under GST Inspection; Business Unaffected, Shares Climb

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Lupin's Maharashtra Office Under GST Inspection; Shares Rise Amidst Strong Financials

Lupin share price, Lupin stock, Lupin shares, Lupin Q3, Lupin Q3 earnings, Lupin Q3 results, Lupin brokerages, Lupin rating, Lupin target price, Lupin buy or sell, buy or sell Lupin, brokerage calls, Lupin stock analysis, Lupin Q3 earnings, Lupin target price, Lupin US sales, Lupin margin guidance, Lupin EPS growth, Lupin brokerage ratings

C

CNBC TV18•25-02-2026, 17:25

Lupin's Maharashtra Office Under GST Inspection; Shares Rise Amidst Strong Financials

•Lupin's Maharashtra office is currently undergoing an inspection and search by the Goods and Services Tax Department.
•The company is fully cooperating with authorities, stating the inspection has no impact on its financials, operations, or other activities.
•The inspection focuses on documents related to GST payments and input tax credit claims.
•Lupin's shares rose 1.90% to ₹2,293 apiece despite the ongoing inspection.
•The company recently launched seizure medication Brivaracetam Oral Solution in the US and reported a 37.5% rise in net profit for Q3 FY25.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Representational image (Image: News18)

Lupin's Goa Plant Receives Satisfactory EIR from USFDA

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

Lupin's Ankleshwar Facility Gets 2 US FDA Observations; Q3 Profit Up 37.5%

Zydus Lifesciences Limited ने गुरुवार, 15 जनवरी को शेयर बाजारों को सूचित किया कि उसे US Food and Drug Administration (US FDA) से Eltrombopag Tablets के लिए अंतिम मंजूरी मिल गई है.

Lupin Secures US FDA Approval for Epilepsy Drug, Eyes Major US Market Launch

US FDA Flags 11 Observations at Eugia Pharma's Telangana Unit

US FDA Flags 11 Observations at Eugia Pharma's Telangana Unit

Lupin said the US drug regulator has classified its inspection of the Pithampur Unit 2 manufacturing facility as 'official action indicated' (OAI).

The US Food and Drug Administration (USFDA) had conducted inspections at the facility from July 8 to July 17, 2025, and closed it by issuing Form 483 with four observations.

Lupin Q3 Net Profit Jumps 38% on Strong US Sales, Divestment Gains

VIP Industries Under GST Inspection in Mumbai, Nashik; Company Cooperating

VIP Industries Under GST Inspection in Mumbai, Nashik; Company Cooperating